Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrests.
Adult
Baltimore
Community Health Services
/ statistics & numerical data
Criminal Law
/ statistics & numerical data
Female
Humans
Male
Methadone
/ therapeutic use
Middle Aged
Narcotics
/ therapeutic use
Opiate Substitution Treatment
/ statistics & numerical data
Opioid-Related Disorders
/ drug therapy
Outcome and Process Assessment, Health Care
Prisoners
/ statistics & numerical data
Prisons
/ statistics & numerical data
Criminal justice
Incarceration
Methadone treatment
Opioid addiction treatment
Opioid agonist treatment
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
08
08
2018
revised:
16
11
2018
accepted:
18
11
2018
entrez:
23
12
2018
pubmed:
24
12
2018
medline:
17
6
2020
Statut:
ppublish
Résumé
The extent to which patient characteristics differ between individuals entering methadone treatment through community programs and jail-based programs is not known. Such differences could impact the likelihood of relapse and recidivism in these two populations and inform efforts at targeting interventions. We compared treatment-entry characteristics of participants enrolling in methadone treatment in two studies conducted in Baltimore, one conducted in community programs (N = 295) and the other in a jail-based program (N = 225). Controlling for age, race, and gender, individuals starting methadone treatment in jail compared to the community, had more severe drug use and criminal justice profiles. These different characteristics suggest that patients initiating methadone in a jail-based program could have greater likelihood of future arrest compared to patients entering community-based treatment. CLINICAL TRIALS REGISTRATION: Clinicaltrials.gov NCT 02334215 and NCT 01442493.
Identifiants
pubmed: 30577902
pii: S0740-5472(18)30380-5
doi: 10.1016/j.jsat.2018.11.006
pmc: PMC6310067
mid: NIHMS1514298
pii:
doi:
Substances chimiques
Narcotics
0
Methadone
UC6VBE7V1Z
Types de publication
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7-13Subventions
Organisme : NIDA NIH HHS
ID : R01 DA015842
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA013636
Pays : United States
Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.
Références
Drug Alcohol Depend. 2015 Apr 1;149:108-16
pubmed: 25702933
Cochrane Database Syst Rev. 2015 Jun 02;(6):CD010862
pubmed: 26035084
Arch Gen Psychiatry. 2006 Jan;63(1):102-9
pubmed: 16389204
Addict Behav. 2008 Jun;33(6):799-811
pubmed: 18258375
Qual Life Res. 2004 Mar;13(2):299-310
pubmed: 15085902
N Engl J Med. 1969 Jun 19;280(25):1372-5
pubmed: 4890477
Contemp Clin Trials. 2016 May;48:166-72
pubmed: 27180088
Cancer Pract. 1995 Jan-Feb;3(1):19-30
pubmed: 7704057
J Subst Abuse Treat. 1992;9(3):199-213
pubmed: 1334156
Drug Alcohol Depend. 2009 Jan 1;99(1-3):222-30
pubmed: 18930603
Drug Alcohol Depend. 2009 Aug 1;103(3):148-54
pubmed: 19443133
Crim Justice Behav. 2013 Jun 1;40(6):690-711
pubmed: 24443612
Am J Drug Alcohol Abuse. 1978;5(4):455-62
pubmed: 755384
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
Contemp Clin Trials. 2016 Jul;49:57-64
pubmed: 27178765
J Subst Abuse. 1995;7(1):117-34
pubmed: 7655308
Am J Addict. 2007 Nov-Dec;16(6):510-20
pubmed: 18058419
JAMA. 2009 Jan 14;301(2):183-90
pubmed: 19141766
J Consult Clin Psychol. 2005 Dec;73(6):1026-35
pubmed: 16392976
Addiction. 2012 Mar;107(3):501-17
pubmed: 21955033
Cochrane Database Syst Rev. 2002;(4):CD002209
pubmed: 12519570
Am J Addict. 2001;10(s1):s70-s85
pubmed: 11268823
JAMA. 1968 Dec 16;206(12):2708-11
pubmed: 5754883
J Stud Alcohol Suppl. 1994 Dec;12:112-8
pubmed: 7722987
J Subst Abuse Treat. 1999 Jun;16(4):329-35
pubmed: 10349606
Proc Natl Conf Methadone Treat. 1973;1:109-15
pubmed: 4808135
Drug Alcohol Depend. 1983 Oct;12(2):119-42
pubmed: 6653385
JAMA. 1971 May 24;216(8):1320-4
pubmed: 5108449
Am J Drug Alcohol Abuse. 1978;5(1):1-22
pubmed: 696703
Contemp Clin Trials. 2016 Jul;49:21-8
pubmed: 27282117
J Subst Abuse Treat. 2015 Sep;56:16-22
pubmed: 25858761
Subst Use Misuse. 1998 Jul;33(9):1817-37
pubmed: 9718181
Addiction. 1998 Aug;93(8):1177-90
pubmed: 9813899
Am J Public Health. 1991 Sep;81(9):1185-91
pubmed: 1659236
Addict Behav. 2018 Sep;84:7-12
pubmed: 29587173
Drug Alcohol Depend. 2017 Nov 1;180:385-390
pubmed: 28961545
Eur Addict Res. 2005;11(1):50-6
pubmed: 15608472
Int J Addict. 1978 Aug;13(6):921-31
pubmed: 730404
J Subst Abuse Treat. 2009 Oct;37(3):277-85
pubmed: 19339140
N Y State J Med. 1972 Jul 1;72(13):1752-5
pubmed: 4504067
Cochrane Database Syst Rev. 2004;(3):CD002207
pubmed: 15266465
Addiction. 2012 Feb;107(2):372-80
pubmed: 21851442
Contemp Clin Trials. 2016 Jul;49:70-7
pubmed: 27282118
J Subst Abuse Treat. 1996 Jan-Feb;13(1):79-83
pubmed: 8699547
Subst Abus. 2012;33(1):19-29
pubmed: 22263710
BMC Psychiatry. 2012 Aug 15;12:111
pubmed: 22894706
Arch Gen Psychiatry. 1981 Aug;38(8):875-80
pubmed: 7259424